It will be very interesting to see what the revenue from the Renasas agreement is in the 4C. I personally will not be surprised if it is minimal.
My reasoning is that Renasas licensed the IP for one particular product, as I understand it. Which product this is, we dont know. If Renasas have not sold any of this particular product, there will be no royalties.
R&D takes time. The deal was done just before Xmas. To expect integration and large sales of what ever product it is going into immediately and subsequent significant royalty revenue to BRN is unrealistic in my view.
ALSO, despite the moaning, the insults, the name calling that is going on in this forum, the last thing that the staff at BRN are concerned about is the share price. They will be focused on the commercialisation of a jewel called AKIDA. When they have something to announce, they will tell us.
It will be very interesting to see what the revenue from the...
Add BRN (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
20.5¢ |
Change
-0.005(2.38%) |
Mkt cap ! $380.4M | |||
| Open | High | Low | Value | Volume |
| 21.0¢ | 22.0¢ | 20.3¢ | $1.148M | 5.421M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 165683 | 20.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 21.0¢ | 10000 | 1 |
View Market Depth
| Last trade - 16.10pm 19/07/2024 (20 minute delay) ? |
| BRN (ASX) Chart |